Related Experiment Videos
Interleukin-12: a recently discovered cytokine with potential for enhancing cell-mediated immune responses to tumors
1Department of Immunopharmacology, Roche Research Center Hoffmann-La Roche Inc., Nutley, New Jersey 07110.
Cancer Investigation
|January 1, 1993
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
In vitro and in vivo responses to interleukin 12 are maintained until the late SIV infection stage but lost during AIDS.
AIDS research and human retroviruses·2000
IL-12 is dispensable for innate and adaptive immunity against low doses of Listeria monocytogenes.
International immunology·1999
Interleukin-12 is essential for a protective Th1 response in mice infected with Cryptococcus neoformans.
Infection and immunity·1998
The interleukin-12/interleukin-12-receptor system: role in normal and pathologic immune responses.
Annual review of immunology·1998
Analysis of the multiple interactions between IL-12 and the high affinity IL-12 receptor complex.
Journal of immunology (Baltimore, Md. : 1950)·1998
Primary Tumor Histologic Regression and Immunotherapy Outcomes in Recurrent or Metastatic Melanoma.
Cancer investigation·2026
The Risk of Hyperglycemia with PI3K Inhibitors in Cancer Patients-A Meta-Analysis.
Cancer investigation·2026
How I Treat: Transplantation for primary immune regulatory diseases and inflammatory disorders.
Journal of human immunity·2026
Advances in Human and Animal Germinal Center Models In Vitro: New Approaches to Studying Immune Responses.
BioMed research international·2026
Simultaneous immune checkpoint blockade-associated diabetes mellitus and thyrotoxicosis.
JCEM case reports·2026